AMGEN: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
What changed
AMGEN
NACE 46.460, Wholesale of pharmaceutical and medical goods
financial year 2024 against 2025filed annual accounts (NBB)
Net result for the year
€6.0m
2024 · €5.6m+€312,565
Equity
€6.8m
2024 · €5.9m+€951,405
Cash
€2,667
2024 · €1,222+€1,445
Balance sheet total
€45.6m
2024 · €39.4m+€6.3m
Largest movements
Assets
- Receivables within one year +€6.4m
up €6.4m (+16.6%), from €38.4m to €44.8m
of which Other amounts receivable: +€6.1m
Equity and liabilities
- Trade debts +€4.2m
up €4.2m (+15.6%), from €26.7m to €30.9m
- Profit (loss) carried forward +€951,405
up €951,405 (+16.8%), from €5.7m to €6.6m
- Accrued charges and deferred income +€471,637
up €471,637 (+23.7%), from €2.0m to €2.5m
Income statement
- Turnover +€20.4m
up €20.4m (+11.6%), from €175.6m to €195.9m
- Other operating charges +€12.5m
up €12.5m (+42.5%), from €29.5m to €42.0m
- Goods and materials +€6.5m
up €6.5m (+6.2%), from €104.6m to €111.1m
- Services and other goods +€2.8m
up €2.8m (+17.8%), from €15.6m to €18.3m
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Result 2024
€5.6m
Turnover
+€20.4m
Other operating income
+€176,127
Goods and materials
-€6.5m
Services and other goods
-€2.8m
Staff costs
-€174,117
Depreciation
-€145,527
Provisions
+€892,736
Other operating charges
-€12.5m
Financial income
-€318,390
Financial charges
+€41,586
Taxes
+€1.3m
Result 2025
€6.0m
Cash bridge derived
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
From operations
+€5.0m
Investment
-€36,823
Financing
-€5.0m
Cash 2024
€1,222
From operations (derived)
+€5.0m
Net result for the year
+€6.0m
Depreciation
+€177,736
Receivables within one year
-€6.4m
Deferred charges and accrued income
-€26,335
Provisions
+€252,826
Trade debts
+€4.2m
Tax, wage and social debts
+€406,294
Accrued charges and deferred income
+€471,637
Investment (derived)
-€36,823
Investment in fixed assets (net)
-€36,823
Financing
-€5.0m
Contributions, distributions and other
-€5.0m
Cash 2025
€2,667
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €39,360,952 | €45,627,006 | +€6.3m | +15.9% |
| Fixed assets | 21/28 | €898,684 | €757,771 | -€140,913 | -15.7% |
| Tangible fixed assets | 22/27 | €898,684 | €757,771 | -€140,913 | -15.7% |
| Plant, machinery and equipment | 23 | €41,487 | €42,986 | +€1,500 | +3.6% |
| Furniture and vehicles | 24 | €92,698 | €62,478 | -€30,220 | -32.6% |
| Other tangible fixed assets | 26 | €725,716 | €642,699 | -€83,017 | -11.4% |
| Assets under construction and advance payments | 27 | €38,783 | €9,607 | -€29,176 | -75.2% |
| Current assets | 29/58 | €38,462,268 | €44,869,235 | +€6.4m | +16.7% |
| Amounts receivable within one year | 40/41 | €38,433,546 | €44,812,734 | +€6.4m | +16.6% |
| Trade receivables | 40 | €31,083,285 | €31,407,909 | +€324,624 | +1.0% |
| Other amounts receivable | 41 | €7,350,261 | €13,404,825 | +€6.1m | +82.4% |
| Cash at bank and in hand | 54/58 | €1,222 | €2,667 | +€1,445 | +118.2% |
| Deferred charges and accrued income | 490/1 | €27,500 | €53,835 | +€26,335 | +95.8% |
| Total equity and liabilities | 10/49 | €39,360,952 | €45,627,006 | +€6.3m | +15.9% |
| Equity | 10/15 | €5,865,846 | €6,817,251 | +€951,405 | +16.2% |
| Contributions | 10/11 | €173,525 | €173,525 | = | 0.0% |
| Capital | 10 | €173,525 | €173,525 | = | 0.0% |
| Issued capital | 100 | €173,525 | €173,525 | = | 0.0% |
| Reserves | 13 | €17,353 | €17,353 | = | 0.0% |
| Non-distributable reserves | 130/1 | €17,353 | €17,353 | = | 0.0% |
| Legal reserve | 130 | €17,353 | €17,353 | = | 0.0% |
| Profit (loss) carried forward | 14 | €5,674,968 | €6,626,373 | +€951,405 | +16.8% |
| Provisions and deferred taxes | 16 | €1,305,594 | €1,558,420 | +€252,826 | +19.4% |
| Provisions for liabilities and charges | 160/5 | €1,305,594 | €1,558,420 | +€252,826 | +19.4% |
| Other liabilities and charges | 164/5 | €1,305,594 | €1,558,420 | +€252,826 | +19.4% |
| Amounts payable | 17/49 | €32,189,512 | €37,251,335 | +€5.1m | +15.7% |
| Amounts payable within one year | 42/48 | €30,199,596 | €34,789,783 | +€4.6m | +15.2% |
| Trade debts | 44 | €26,747,474 | €30,931,367 | +€4.2m | +15.6% |
| Suppliers | 440/4 | €26,747,474 | €30,931,367 | +€4.2m | +15.6% |
| Taxes, remuneration and social security | 45 | €3,452,122 | €3,858,416 | +€406,294 | +11.8% |
| Taxes | 450/3 | - | €192,442 | +€192,442 | |
| Remuneration and social security | 454/9 | €3,452,122 | €3,665,974 | +€213,852 | +6.2% |
| Accrued charges and deferred income | 492/3 | €1,989,916 | €2,461,553 | +€471,637 | +23.7% |
| Operating income | 70/76A | €177,822,241 | €198,373,926 | +€20.6m | +11.6% |
| Turnover | 70 | €175,558,223 | €195,933,782 | +€20.4m | +11.6% |
| Other operating income | 74 | €2,264,018 | €2,440,145 | +€176,127 | +7.8% |
| Operating charges | 60/66A | €169,775,918 | €190,992,003 | +€21.2m | +12.5% |
| Goods for resale, raw materials and consumables | 60 | €104,617,562 | €111,108,672 | +€6.5m | +6.2% |
| Purchases | 600/8 | €104,617,562 | €111,108,672 | +€6.5m | +6.2% |
| Services and other goods | 61 | €15,554,475 | €18,321,866 | +€2.8m | +17.8% |
| Remuneration, social security and pensions | 62 | €18,972,589 | €19,146,706 | +€174,117 | +0.9% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €32,209 | €177,736 | +€145,527 | +451.8% |
| Provisions for liabilities and charges: additions (uses and reversals) | 635/8 | €1,145,562 | €252,826 | -€892,736 | -77.9% |
| Other operating charges | 640/8 | €29,453,520 | €41,984,197 | +€12.5m | +42.5% |
| Operating profit (loss) | 9901 | €8,046,323 | €7,381,923 | -€664,400 | -8.3% |
| Financial income | 75/76B | €720,284 | €401,894 | -€318,390 | -44.2% |
| Recurring financial income | 75 | €720,284 | €401,894 | -€318,390 | -44.2% |
| Income from current assets | 751 | €720,284 | €401,894 | -€318,390 | -44.2% |
| Financial charges | 65/66B | €176,804 | €135,218 | -€41,586 | -23.5% |
| Recurring financial charges | 65 | €176,804 | €135,218 | -€41,586 | -23.5% |
| Debt charges | 650 | €128,037 | €134,455 | +€6,418 | +5.0% |
| Other financial charges | 652/9 | €48,767 | €762 | -€48,004 | -98.4% |
| Profit (loss) for the period before taxes | 9903 | €8,589,804 | €7,648,600 | -€941,204 | -11.0% |
| Income taxes | 67/77 | €2,950,964 | €1,697,195 | -€1.3m | -42.5% |
| Taxes | 670/3 | €2,950,964 | €2,050,582 | -€900,382 | -30.5% |
| Tax adjustments and reversals of tax provisions | 77 | - | €353,387 | +€353,387 | |
| Profit (loss) for the period | 9904 | €5,638,840 | €5,951,405 | +€312,565 | +5.5% |
| Profit (loss) for the period to be appropriated | 9905 | €5,638,840 | €5,951,405 | +€312,565 | +5.5% |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 12 October 2026 via checked.be.